Skip to Main ContentSkip to FooterSkip to Search

Development Strategies for Difficult to Express Proteins

Summary: Biopharmaceutical products in development continue to increase in complexity. These include numerous multi-specific antibody platforms, proteins that require cleavage, or other additional post-translational modifications…